🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase IV, multi-center, double-blind, randomized, placebo- contro...
Status
Terminated
Location
San Francisco VA Medical Center
Start Date
2018-08-04
Trial ID
NCT03542110
Treatments Being Tested
Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors increase LDL re...
Status
Unknown
Location
Eduard Ilgiyaev
Start Date
2019-01
Trial ID
NCT03634293
Treatments Being Tested
Aim 1: To determine whether therapy with Alirocumab, compared to pre-treatm...
Status
Unknown
Location
Westside Medical Associates of Los Angeles
Start Date
2016-11
Trial ID
NCT02992301
Treatments Being Tested
Primary Objectives: * To demonstrate the superiority of alirocumab in comp...
Status
Completed
Location
Investigational Site Number 840020
Start Date
2015-10-23
Trial ID
NCT02585778
Treatments Being Tested
Primary Objective: To assess the long-term safety of alirocumab (SAR236553...
Status
Completed
Location
Investigational Site Number 840321
Start Date
2013-12-17
Trial ID
NCT01954394
Treatments Being Tested
Primary Objective: To demonstrate the reduction of low-density lipoprotein...
Status
Completed
Location
Investigational Site Number 840703
Start Date
2013-12-16
Trial ID
NCT02023879
Treatments Being Tested
Primary Objective: To demonstrate the superiority of alirocumab in compari...
Status
Completed
Location
Investigational Site Number 840-163
Start Date
2016-03-15
Trial ID
NCT02642159
Treatments Being Tested
The main purpose of this study is to evaluate the effect on mental state (k...
Status
Completed
Location
Regeneron Study Site
Start Date
2016-11-02
Trial ID
NCT02957682
Treatments Being Tested
This will be a randomized double blind placebo-controlled pilot study using...
Status
Terminated
Location
University of Utah
Start Date
2018-10-30
Trial ID
NCT03507374
Treatments Being Tested